Clinical Trial Update: AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial evaluating AK112 in combination with platinum-based chemotherapy for EGFR/ALK/ROS1-positive non-small cell lung cancer, with Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Efficacy | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING